Pulmonary Arterial Hypertension Clinical Trials in Louisville, Kentucky

5 studies are recruiting for pulmonary arterial hypertension in Louisville, Kentucky right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

   Researchers are looking for more ways to treat PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood to flow. This causes high blood pressure in the lungs and overworks the heart. PAH can make it hard to breathe and be active. Some standard (usual) tre…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Norton Pulmonary Specialists ( Site 1066), Louisville, Kentucky

   Locations

   136 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT07218029 on ClinicalTrials.gov

2. An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

   This is an adaptive, 2-part, randomized, multicenter, double-blind, placebo-controlled, parallel-group study designed to evaluate the efficacy and safety of IKT-001 in adult participants with WHO Group 1 PAH.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Norton Healthcare, Louisville, Kentucky

   Locations

   43 in total

   Run by

   Inhibikase Therapeutics

   See if you can join NCT07365332 on ClinicalTrials.gov

3. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

   The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK…

   Stage

   Not phased

   Ages

   0 to 20

   Site

   University of Louisville Norton Childrens Hospital, Louisville, Kentucky

   Locations

   52 in total

   Run by

   Duke University

   See if you can join NCT04278404 on ClinicalTrials.gov

4. Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

   This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Norton Pulmonary Specialists, Louisville, Kentucky

   Locations

   120 in total

   Run by

   Gossamer Bio USA, Inc.

   See if you can join NCT06274801 on ClinicalTrials.gov

5. Pulmonary Hypertension Association Registry

   The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people with PAH and CTEPH who are cared for in participating PHA-accredited Pulmonary Hypertension Care C…

   Stage

   Not phased

   Ages

   0 and older

   Site

   Kentuckiana Pulmonary Associates, Louisville, Kentucky

   Locations

   52 in total

   Run by

   Pulmonary Hypertension Association, Inc.

   See if you can join NCT04071327 on ClinicalTrials.gov